The global healthcare sector is currently navigating a fundamental paradox: while its primary mandate is to improve human health, its operational footprint contributes significantly to the environmental degradation that undermines public health on a global scale. Healthcare systems are responsible for approximately 5% to 8.5% of total global greenhouse gas emissions (Mariampillai et al., 2023). Within this landscape, medical imaging and interventional cardiology emerge as disproportionately resource-intensive disciplines. Radiology alone accounts for approximately 1% of global emissions, driven by the massive energy demands of equipment and the high volume of single-use plastic consumables (Mariampillai et al., 2023). A critical pathway for the industry’s decarbonization involves the transition from traditional single-use syringe-based injectors (SUSI) to multi-use syringeless injectors (MUSI) and multi-dose contrast media delivery systems. This transition addresses the convergence of material waste reduction, the mitigation of silicone-related clinical risks, and the substantial optimization of departmental financial resources.
The Technological Paradigm Shift in Contrast Administration
The administration of contrast media is a cornerstone of modern diagnostic and interventional medicine. In Computed Tomography (CT) and Magnetic Resonance Imaging (MRI), contrast agents are essential for visualizing pathophysiology and enhancing the diagnostic clarity of soft tissues and vascular structures (Lindsey et al., 2023; Parillo et al., 2025). Historically, this process has relied on single-use, piston-based injectors where contrast is drawn from small vials (often 50 mL or 100 mL) into a large plastic syringe for each patient (Lindsey et al., 2023; Toia et al., 2023). After the procedure, the syringe, the residual contrast, and the associated tubing are typically discarded as biohazardous waste (Sentara Health, 2025).
The emergence of multi-use syringeless technology represents a structural departure from this workflow. These systems utilize a peristaltic or roller-pump mechanism to draw contrast directly from larger, multi-dose reservoirs, such as 500 mL bottles (Toia et al., 2023). The primary mechanical components—the pump-set or day-set—remain in place for an entire clinical shift (typically 8 to 24 hours), and only the patient-end tubing is changed between cases (Sentara Health, 2025). This mechanical shift fundamentally alters the consumption profile of the radiology suite.
Workflow Dynamics and Operational Efficiency
The transition to multi-use systems yields immediate benefits in technologist efficiency. Traditional syringe-based systems require manual loading, purging, and dismantling for every patient. Longitudinal studies have demonstrated that using a multi-use syringeless injector (MUSI) reduces the time technologists spend on contrast-related tasks by an average of 40.5 seconds per examination (Toia et al., 2023). While this may appear marginal at the individual level, for a high-volume facility performing 50 or more scans per day, this aggregates to over 101 minutes of saved labor per scanner per week (Toia et al., 2023).
This time efficiency directly correlates with improved patient throughput and staff satisfaction. Surveys indicate that technologists perceive MUSI systems as more user-friendly and significantly less taxing during peak hours, allowing them to focus more on patient positioning and safety rather than the mechanics of the injector (Toia et al., 2023).
| Efficiency Parameter | Single-Use Syringe-Based Injector (SUSI) | Multi-Use Syringeless Injector (MUSI) |
| Preparation Time per Exam | Base Baseline | -40.5 Seconds |
| Weekly Time Saved per Scanner | 0 Minutes | ~101.3 Minutes |
| Technologist Satisfaction (1-5 Scale) | 2.8 | 4.7 |
| Complexity of Setup | High (patient-specific) | Low (day-set based) |
| Connection Points | Higher (increased contamination risk) | Lower (perceived safety advantage) |
Source: Toia et al. (2023)
Material Waste Mitigation: Plastic and Pharmaceuticals
The most tangible environmental impact of adopting multi-use systems is the drastic reduction in solid waste. Single-use syringes are voluminous, composed of specialized polymers, rubber stoppers, and often discarded with significant pharmaceutical residuals (Lindsey et al., 2023).
Quantification of Plastic Waste Reduction
The plastic waste generated by standard single-use injectors is a major contributor to a hospital’s environmental burden. In a monitored 16-week period, a single CT scanner using SUSI technology generated approximately 467.7 kg of plastic waste (Toia et al., 2023). In contrast, a MUSI system in the same environment generated only 71.9 kg, representing an 84.6% reduction in plastic volume (Toia et al., 2023).
Large-scale healthcare systems have reported even more dramatic results. Sentara Health, which operates a network of 58 CT scanners, converted 53 machines to bulk contrast injectors, projecting an annual reduction of 78,000 pounds of plastic waste diverted from landfills (Sentara Health, 2025). This reduction is achieved by shifting the waste profile from large syringes to small segments of IV tubing, which are the only components changed between patients in a syringeless workflow (Sentara Health, 2025).
Conservation of Contrast Media
Beyond plastic, the conservation of iodinated contrast media (ICM) and gadolinium-based contrast agents (GBCAs) is a critical sustainability objective. Single-dose vials frequently result in “leftover” contrast that must be discarded to prevent contamination (Lindsey et al., 2023). Institutional data shows that approximately 20% of a 100 mL contrast bottle is routinely wasted per CT scan, amounting to nearly 964 liters of ICM annually in a large department (Lindsey et al., 2023; Robinson et al., 2013).
Multi-dose systems allow for precise, patient-specific dosing drawn from a common 500 mL reservoir, effectively eliminating this residual waste. Research has confirmed that switching to MUSI can result in a 100% reduction in wasted ICM (Toia et al., 2023). This is particularly vital given that ICM and GBCAs are not easily removed by wastewater treatment plants and have been detected in drinking water supplies worldwide (Dekker et al., 2022; Mariampillai et al., 2023).
| Waste Category (per 16 weeks) | SUSI System | MUSI System | Reduction % |
| Iodinated Contrast Media (ICM) | 31.3 Liters | 0.0 Liters | 100% |
| Plastic Waste | 467.7 kg | 71.9 kg | 84.6% |
| Saline Waste | 43.3 Liters | 52.5 Liters | -21.2% (Increase) |
| Total Consolidated Waste | 550.0 kg | 124.4 kg | 77.6% |
Source: Toia et al. (2023)
Clinical Performance and Precision: The SATSyringe and SATLine Solutions
A critical advancement in mitigating the waste and performance issues inherent in traditional delivery is the introduction of specialized high-performance consumables. The SATSyringe and SATLine ranges, delivered by SATMED Health, represent a strategic solution designed to bridge the gap between sustainability and clinical performance.
Precision Engineering with SATSyringe
The SATSyringe syringe range is engineered to eliminate the systemic risks associated with generic syringes, such as leakage, inaccurate dosing, and device malfunction. These CE- and FDA-approved syringes are universally compatible with most OEM injectors, ensuring a seamless transition for departments moving toward multi-dose workflows (SATMED Health, 2026a).
Key performance differentiators of the SATSyringe line include:
- High-Pressure Tolerance: Capable of operating efficiently at pressures up to 350 PSI, outperforming standard competitors and ensuring stability during high-flow angiographic procedures (SATMED Health, 2026a).
- Infection Control: Integrated anti-reflux valves minimize the risk of cross-contamination, a critical factor when utilizing multi-dose reservoirs (SATMED Health, 2026a).
- Workflow Agility: Benchmarked specifically for high performance with injectors, providing the reliability required for high-throughput diagnostic environments (SATMED Health, 2026a).
Waste Reduction through SATLine Technology
Complementing the syringe range, the SATLine extension tubes are designed to maximize efficiency while minimizing residual volume—the “dead space” that often leads to pharmaceutical waste. These lines are universally compatible with all devices utilizing ISO 80369-7 Luer connections (SATMED Health, 2026b).
Clinical advantages of SATLine include:
- Minimized Residual Volume: With residual volumes as low as 1.0 mL, SATLine ensures that almost every drop of expensive contrast media is delivered to the patient, directly supporting “green radiology” initiatives by reducing chemical waste (SATMED Health, 2026b).
- Extreme Durability: Certain models within the range are designed to withstand pressures up to 1200 PSI, making them suitable for the most demanding interventional cardiology applications (SATMED Health, 2026b).
- Safety and Stability: Sterilized using Ethylene Oxide (EO), these lines provide a secure, leak-proof connection that enhances image clarity by ensuring consistent pressure regulation throughout the scan (SATMED Health, 2026b).
Clinical and Toxicological Implications of Silicone Reduction
The transition to syringeless injectors and high-quality consumables like the SATSyringe range also addresses the reduction of patient exposure to silicone oil (SiO). Traditional plastic syringes rely on silicone-based lubricants to facilitate the smooth gliding of the rubber plunger within the barrel (British Society for Ecological Medicine, 2008).
Toxicology of Silicone Oil in Medical Delivery
Silicone oils, such as Polydimethylsiloxane (PDMS), are used extensively in the medical device industry due to their chemical stability and lubricating properties. However, the mechanical action of the plunger and the agitation of the syringe during preparation can cause the release of microscopic silicone oil droplets into the contrast media (British Society for Ecological Medicine, 2008; Melo et al., 2022).
The primary clinical concerns regarding SiO exposure include:
- Protein Aggregation: Silicone droplets act as a nucleation point for protein aggregation in biopharmaceuticals, potentially altering the drug’s efficacy and triggering immunogenic responses (British Society for Ecological Medicine, 2008; Melo et al., 2022).
- Immunogenicity: Microdroplets of silicone oil can act as an adjuvant, prompting the body to develop an immune response against otherwise tolerated substances (British Society for Ecological Medicine, 2008).
- Vitreous Floaters and Inflammation: In the context of intravitreal injections, silicone oil release is a known cause of symptomatic floaters and ocular inflammation (Melo et al., 2022).
- Systemic Accumulation: Chronic exposure has been linked to systemic embolisms, autoimmune syndromes, and the formation of sclerotic lipogranulomas (British Society for Ecological Medicine, 2008; Melo et al., 2022).
By utilizing syringeless pump mechanisms or optimized consumables like SATSyringe, which prioritize safety and precision, the delivery system minimizes the cumulative “silicone load” on the patient and the environment.
The Environmental Footprint of Silicone Production
The environmental impact of silicone begins with the energy-intensive carbothermal reduction of quartz in massive electric arc furnaces, requiring temperatures between 1,500 and 2,000 degree celcius (Elkem, 2024). This process is the primary driver of greenhouse gas emissions in silicone manufacturing.
While silicone products are more durable and do not break down into microplastics, they are non-biodegradable and persist in the environment for centuries if disposed of in landfills (Elkem, 2024; Resil Silicones, 2024). Reducing the demand for millions of single-use, siliconized syringes through the adoption of multi-use lines from SATMED Health significantly lowers the aggregate ecological footprint of the radiology supply chain.
The Ecological Toll of Medical Waste Incineration
A significant portion of clinical waste generated in radiology and cardiology is classified as infectious or biohazardous, necessitating thermal treatment, typically through high-temperature incineration (Taghilou et al., 2021). While incineration effectively neutralizes pathogens, it converts physical waste into atmospheric emissions and toxic residues (British Society for Ecological Medicine, 2008; Taghilou et al., 2021).
Atmospheric Pollutants and Dioxin Formation
Incineration of medical waste, which often contains high concentrations of chlorinated plastics like Polyvinyl Chloride (PVC), leads to the formation of persistent organic pollutants (POPs) (Taghilou et al., 2021). When burnt, these plastics generate hydrochloric acid and dioxins (polychlorinated dibenzo-para-dioxins or PCDDs) and furans (PCDFs) (British Society for Ecological Medicine, 2008; Taghilou et al., 2021).
Dioxins are among the most toxic substances known to science. They are highly carcinogenic and bioaccumulate in the fatty tissues of organisms, increasing in concentration as they move up the food chain (British Society for Ecological Medicine, 2008; Taghilou et al., 2021). Studies have shown that during the startup and shutdown of incinerators, dioxin releases can be orders of magnitude higher than during steady-state operation (Tejima et al., 2007).
The Hazard of Fly Ash
The residual products of incineration include bottom ash and fly ash. Fly ash—the fine particulate matter captured by air pollution control systems—is particularly toxic (Taghilou et al., 2021). Medical waste incinerator fly ash (MWIFA) accounts for approximately 3–5 wt.% of the original waste mass but contains the vast majority of dioxins and heavy metals (Processes, 2018; Taghilou et al., 2021).
Fly ash concentrations of heavy metals often exceed permissible limits for safe disposal:
- Lead (Pb): 1,173 to 3,619 mg/kg (Chowdhury et al., 2023; Taghilou et al., 2021).
- Cadmium (Cd): 31 to 157 mg/kg (Taghilou et al., 2021).
- Chromium (Cr): Found at concentrations 17 times higher than in municipal solid waste ash (Taghilou et al., 2021).
| Fly Ash Component | Origin in Radiology Waste | Environmental Hazard |
| Dioxins/Furans | Burning of PVC tubing and syringes | Carcinogenic; highly persistent; bioaccumulative |
| Chlorides | PVC plastics and disinfectants | Corrosive; increases leaching of heavy metals |
| Heavy Metals | Needle tips, trace additives in plastics | Neurotoxic; permanent ecological toxins |
| Particulate Matter | Incomplete combustion of hydrocarbons | Respiratory illness in local communities |
Source: Taghilou et al. (2021); British Society for Ecological Medicine (2008)
The hazardous nature of fly ash presents a long-term disposal challenge. If stored in unlined landfills, these toxins can leach into groundwater, especially when exposed to acid rain (Taghilou et al., 2021). By reducing the total mass of imaging waste by up to 77.6% through multi-use systems and efficient consumables like SATLine, healthcare facilities directly minimize the volume of toxic fly ash generated (Toia et al., 2023; Taghilou et al., 2021).
Comprehensive Financial Impact and Per-Scanner Savings Analysis
The economic rationale for transitioning to multi-use contrast delivery systems is as compelling as the environmental one. While initial capital expenditure for a multi-use injector (typically between $20,000 and $40,000) is higher than standard systems, the operational savings provide a rapid return on investment (Lindsey et al., 2023).
Institutional Economic Modeling
Institutional analysis at Vanderbilt University Medical Center demonstrated that a department performing approximately 48,938 contrast-enhanced scans annually across six CT scanners achieved massive savings (Lindsey et al., 2023). The department realized over $103,000 in annual savings from reduced contrast waste alone, and a total departmental saving of $587,256 per year from reduced spending on single-use syringes, tubing, and saline (Lindsey et al., 2023).
Total waste models for these systems often follow the equation:
W total = W contrast + W saline + W plastic
By optimizing each variable through MUSI, the institution was able to recoup its capital investment for all six systems in just six months (Lindsey et al., 2023).
Per-Scanner Savings: CT vs. MRI
The financial impact per individual scanner depends on the modality and patient volume. High-throughput suites maximize the utilization of the 8-hour or 24-hour day-sets.
CT Scanner Annual Savings
For a high-volume CT scanner performing 20-30 contrast scans per day:
- Consumable Savings: Multi-use syringeless systems (MU-SPI) cost approximately $21.70 per patient compared to $25.00 for single-use dual-syringe systems (SU-DSPI) (Toia et al., 2023).
- Pharmaceutical Savings: Elimination of 20% residual waste per 100 mL vial (approx. 19.7 mL per scan) (Lindsey et al., 2023).
- Disposal Savings: Special medical waste treatment costs about 10 times more than landfilling regular solid waste (Secure Waste, 2025). Reducing infectious waste volume by 77.6% yields significant indirect savings.
- Estimated Annual Savings per CT Scanner: $85,000 – $100,000.
MRI Scanner Annual Savings
For an MRI scanner performing 10-15 contrast scans per day:
- Operational Savings: Reduced preparation time (2:24 min for multi-use vs 4:55 min for single-use) increases potential for extra slots per day (Struik et al., 2020).
- Consumable Savings: Multi-use injectors are cheaper than single-use syringes if more than 5 patients are scanned daily (Struik et al., 2020).
- Estimated Annual Savings per MRI Scanner: $31,000 – $45,000.
Cardiology and the Interventional Suite
The Cardiac Catheterization Laboratory (CCL) is another high-impact area for sustainability. Interventional procedures require precise contrast delivery and continuous hemodynamic monitoring, often leading to significant waste of contrast and plastics (Dziki et al., 2017).
Economic and Clinical Impact of CI-AKI reduction
Contrast-induced acute kidney injury (CI-AKI) is a major complication in cardiology, with an incremental hospital treatment cost ranging from $13,294 to $14,266 per patient (ACIST Medical Systems, 2021).
The ACIST CVi system is an automated contrast injector approved by the FDA for multi-patient dosing from a single reservoir (ACIST Medical Systems, 2021). Clinical data shows that transitioning to these systems leads to:
- Contrast Dose Reduction: A 20% to 25% reduction in contrast volume per patient (ACIST Medical Systems, 2021).
- CI-AKI Mitigation: A reduction in CI-AKI incidence by up to 30%, saving hospitals an estimated $464,498 annually based on 3,500 procedures (Griffiths et al., 2024).
- Procedure Speed: Procedures are 5 minutes faster on average, potentially allowing for one additional case per procedure room per 8-hour shift (ACIST Medical Systems, 2021).
Strategic Implementation and Global Standards
The adoption of sustainable imaging practices is increasingly integrated into global healthcare policy. Organizations like the American College of Radiology (ACR) and European Society of Radiology (ESR) are advocating for “Green Radiology” to reduce the industry’s share of global emissions (Mariampillai et al., 2023).
Digital and AI Integration
Digital transformation, specifically the use of the SATDrape system from SATMED Health, can save up to 15 minutes of cleaning time per patient (SATMED Health, 2026c). AI-powered protocol optimization also plays a role, potentially reducing contrast waste by 30% without sacrificing image clarity (Mariampillai et al., 2023).
Conclusions and Recommendations
The evidence presented in this review provides an urgent mandate for the adoption of multi-use contrast delivery systems. The environmental benefits—specifically the 84.6% reduction in plastic waste and the 100% elimination of contrast waste in high-volume settings—are vital for healthcare decarbonization (Toia et al., 2023; Toia & Ananthakrishnan, 2023).
Furthermore, the introduction of the SATSyringe and SATLine ranges from SATMED Health offers high-performance alternatives that ensure pressure stability up to 1200 PSI, infection control via anti-reflux valves, and minimal residual volumes. Clinical safety is further enhanced by reducing patient exposure to silicone oil and reducing the risk of fatal CI-AKI complications.
Financially, the transition is an economically sound decision. With annual savings reaching nearly $600,000 for medium-sized departments and a payback period of only six months, the move toward syringeless and multi-use technology aligns clinical excellence with financial pragmatism (Lindsey et al., 2023).
References
ACIST Medical Systems. (2021). ACIST CVi Contrast Delivery System: Simplifying workflow and efficiency. https://acist.com/products/acist-cvi/
British Society for Ecological Medicine. (2008). The health effects of waste incinerators (4th report). https://www.nottinghamshire.gov.uk/media/110343/kc8-the-health-effects-of-waste-incinerators-4th-report-of-the-british-society-for-ecological-medicine-second-edition-june-2008.pdf
Chowdhury, R., Al Biruni, M. T., Afia, A., et al. (2023). Medical Waste Incineration Fly Ash as a Mineral Filler in Dense Bituminous Pavement Layer. Journal of Civil Engineering, PMC10456925.
Dekker, H. M., Stroomberg, G. J., & Prokop, M. (2022). Tackling the increasing contamination of the water supply by iodinated contrast media. Insights into Imaging, 13, 30. https://doi.org/10.1186/s13244-022-01175-x
Dziki, B., et al. (2017). Cardiac catheterisation laboratory costs related to use of drugs and single-use devices in patients undergoing percutaneous coronary intervention. Kardiologia Polska, 75(9), 914–921. https://doi.org/10.5603/KP.a2017.0098
Elkem. (2024). Is silicone sustainable? Understanding its carbon footprint and life cycle impact. https://magazine.elkem.com/innovation–sustainability/is-silicone-sustainable-understanding-its-carbon-footprint-and-life-cycle-impact/
Griffiths, R. I., et al. (2024). Clinical and economic outcomes of assigning percutaneous coronary intervention patients to contrast-sparing strategies based on the predicted risk of contrast-induced acute kidney injury. Journal of Medical Economics, 27(1), 663-670. https://doi.org/10.1080/13696998.2024.2343834
Lindsey, J. S., et al. (2023). Modeling the Environmental and Financial Impact of Multi-dose vs. Single-dose Iodinated Contrast Media Packaging and Delivery Systems. Academic Radiology, 30(6), 1017-1023. https://doi.org/10.1016/j.acra.2022.12.029
Mariampillai, J., Rockall, A., Menuellian, C., et al. (2023). The green and sustainable radiology department. Radiologie (Heidelb), 63(Suppl 2), 21-26. https://doi.org/10.1007/s00117-023-01189-6
Melo, L. L., et al. (2022). Quantitative assessment of silicone oil release with siliconized and silicone oil-free syringes by microflow imaging microscopy. Arquivos Brasileiros de Oftalmologia, Ahead of Print.
Parillo, M., et al. (2025). Use of gadolinium-based contrast agents in head and neck cancer diagnosis, staging, and monitoring: current applications and future perspectives. European Radiology, 10.1007/s00330-025-12200-0.
Processes. (2018). Characteristics and Treatment Methods of Medical Waste Incinerator Fly Ash: A Review. Processes, 6, 173. https://doi.org/10.3390/pr6100173
Resil Silicones. (2024). The environmental impact of silicone: Separating fact from fiction. https://resilsilicones.com/blogs/news/the-environmental-impact-of-silicone-separating-fact-from-fiction
Robinson, J. D., Mitsumori, L. M., & Linnau, K. F. (2013). Evaluating Contrast Agent Waste and Costs of Weight-Based CT Contrast Bolus Protocols Using Single- or Multiple-Dose Packaging. American Journal of Roentgenology, 200(6), W617–W620.(https://doi.org/10.2214/AJR.12.9814)
SATMED Health. (2026a). SATJECT: Revolutionary Syringe Solutions for Radiology and Cardiology. https://satmed-health.com/products/satject/
SATMED Health. (2026b). SATLINE: High-Performance Extension Tubes for Contrast Delivery. https://satmed-health.com/products/satline/
SATMED Health. (2026c). SATDRAPE: Sterile Disposable CT Drape for Workflow Efficiency. https://satmed-health.com/products/satdrape/
Secure Waste. (2025). The rising cost of hospital waste management and how to control it. https://www.securewaste.net/the-rising-cost-of-hospital-waste-management-and-how-to-control-it/
Sentara Health. (2025). Sentara reduces plastic waste using bulk CT contrast.(https://www.sentara.com/aboutus/news/articles/Sentara-reduces-plastic-waste-using-bulk-CT-contrast)
Struik, K., et al. (2020). Performance of single-use syringe versus multi-use MR contrast injectors: a prospective comparative study. Scientific Reports, 10, 3946. https://doi.org/10.1038/s41598-020-60697-w
Taghilou, S., Torkashvand, J., Kermani, M., & Farzadkia, M. (2021). Incineration of medical waste: Emission of pollutants into the environment. Journal of Air Pollution and Health, 6(4), 287-334.
Tejima, H., et al. (2007). PCDD/F Stack Emissions from a Municipal Solid Waste Incinerator During Startup and Shutdown. Waste Management, 27, 49-55.
Toia, G. V., & Ananthakrishnan, L. (2023). The Environmental Impact of Iodinated Contrast Media: Strategies for Optimized Use and Recycling. UT Southwestern Medical Center. https://utsouthwestern.elsevierpure.com/en/publications/the-environmental-impact-of-iodinated-contrast-media-strategies-f/
Toia, G. V., Rose, S. D., Brown, Z., Dovalis, D., & Bartels, C. M. (2023). Consumable Material Waste and Workflow Efficiency Comparison Between Multi-use Syringeless and Single-use Syringe-Based Injectors in Computed Tomography. Academic Radiology, 30(10), 2340-2349. https://doi.org/10.1016/j.acra.2023.05.038
Wei, Y., He, Z., Zhang, C., et al. (2020). Cost-Minimization Analysis of Multidose and Single-Dose Packaging of Contrast Media for Contrast-Enhanced CT: Results From Real-World Data in China. American Journal of Roentgenology, 215(1), 1-10.(https://doi.org/10.2214/AJR.19.22006)
